Frazier Life Sciences Acquisition Corp. II (FLSC) completed its initial public offering, raising $75,000,000 through Class A ordinary shares. The offering comprised 7,500,000 shares at $10.00 each. The shares began trading on The Nasdaq Capital Market on October 14, 2026. Jefferies acted as sole book-running manager.
The special purpose acquisition company was formed to complete a merger or similar business combination with one or more businesses. It intends to seek biotechnology opportunities, although it may pursue an acquisition in any industry or geography. Its sponsor is Frazier Life Sciences Holdings II, an affiliate of Frazier Life Sciences Management. The company is led by Chief Executive Officer Albert Cha, Chairman Ben Palleiko and Chief Business Officer Kevin Li.